Petitions for compassionate release soared in the pandemic, but federal judges denied most requests. This week officials will review guidelines aimed at freeing imprisoned people who pose no threat.
Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.
They came to tell Congress about their “recovery plan” for physicians, which includes a Medicare pay boost and an end to some frustrating insurance company requirements.
Marburg virus is hard to detect early on–and goes on to kill about half its victims. Researchers hope to work quickly during this outbreak to make progress on emerging vaccines and treatments.
Politicians are again pointing fingers over cutting Medicare. Any party accused of threatening the program tends to lose elections, but without a bipartisan agreement, seniors stand to lose the most.
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.
She’s seen what happens when people don’t trust or understand their doctor. Dr. Lisa Fitzpatrick founded ‘Grapevine Health’ to get solid information out, especially to Black and Latinx patients.
More and more hospitals are contracting with private companies to run their emergency departments. To save money, many are increasingly relying on nurses and physician assistants instead of doctors.
Increasingly, private equity firms shape staffing decisions at hospital emergency rooms, research shows. One apparent effect: Hiring fewer doctors and more health care practitioners who earn far less.